248 related articles for article (PubMed ID: 27084281)
1. Pain mechanisms and ultrasonic inflammatory activity as prognostic factors in patients with psoriatic arthritis: protocol for a prospective, exploratory cohort study.
Højgaard P; Christensen R; Dreyer L; Mease P; de Wit M; Skov L; Glintborg B; Christensen AW; Ballegaard C; Bliddal H; Bukhave K; Bartels EM; Amris K; Ellegaard K; Kristensen LE
BMJ Open; 2016 Apr; 6(4):e010650. PubMed ID: 27084281
[TBL] [Abstract][Full Text] [Related]
2. Pain Mechanisms and Ultrasonic Inflammatory Activity as Prognostic Factors in Patients With Psoriatic Arthritis: A Prospective Cohort Study.
Højgaard P; Ellegaard K; Nielsen SM; Christensen R; Guldberg-Møller J; Ballegaard C; Dreyer L; Mease P; de Wit M; Skov L; Glintborg B; Bliddal H; Bartels EM; Amris K; Kristensen LE
Arthritis Care Res (Hoboken); 2019 Jun; 71(6):798-810. PubMed ID: 29975012
[TBL] [Abstract][Full Text] [Related]
3. Can the painDETECT Questionnaire score and MRI help predict treatment outcome in rheumatoid arthritis: protocol for the Frederiksberg hospital's Rheumatoid Arthritis, pain assessment and Medical Evaluation (FRAME-cohort) study.
Rifbjerg-Madsen S; Christensen AW; Boesen M; Christensen R; Danneskiold-Samsøe B; Bliddal H; Bartels EM; Locht H; Amris K
BMJ Open; 2014 Nov; 4(11):e006058. PubMed ID: 25394817
[TBL] [Abstract][Full Text] [Related]
4. Pain and pain mechanisms in patients with inflammatory arthritis: A Danish nationwide cross-sectional DANBIO registry survey.
Rifbjerg-Madsen S; Christensen AW; Christensen R; Hetland ML; Bliddal H; Kristensen LE; Danneskiold-Samsøe B; Amris K
PLoS One; 2017; 12(7):e0180014. PubMed ID: 28686639
[TBL] [Abstract][Full Text] [Related]
5. Clinical and ultrasonographic predictors for achieving minimal disease activity in patients with psoriatic arthritis: the UPSTREAM (Ultrasound in PSoriatic arthritis TREAtMent) prospective observational study protocol.
Canzoni M; Piga M; Zabotti A; Scirè CA; Carrara G; Olivieri I; Iagnocco A
BMJ Open; 2018 Jul; 8(7):e021942. PubMed ID: 29991631
[TBL] [Abstract][Full Text] [Related]
6. Real-world validation of the minimal disease activity index in psoriatic arthritis: an analysis from a prospective, observational, biological treatment registry.
Rahman P; Zummer M; Bessette L; Baer P; Haraoui B; Chow A; Kelsall J; Kapur S; Rampakakis E; Psaradellis E; Lehman AJ; Nantel F; Osborne B; Tkaczyk C
BMJ Open; 2017 Aug; 7(8):e016619. PubMed ID: 28855200
[TBL] [Abstract][Full Text] [Related]
7. The Swedish Early Psoriatic Arthritis Registry 5-year Followup: Substantial Radiographic Progression Mainly in Men with High Disease Activity and Development of Dactylitis.
Geijer M; Lindqvist U; Husmark T; Alenius GM; Larsson PT; Teleman A; Theander E
J Rheumatol; 2015 Nov; 42(11):2110-7. PubMed ID: 26472410
[TBL] [Abstract][Full Text] [Related]
8. Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study.
Michelsen B; Kristianslund EK; Hammer HB; Fagerli KM; Lie E; Wierød A; Kalstad S; Rødevand E; Krøll F; Haugeberg G; Kvien TK
Ann Rheum Dis; 2017 Apr; 76(4):708-711. PubMed ID: 27707730
[TBL] [Abstract][Full Text] [Related]
9. Differing local and systemic inflammatory burden in polyarticular psoriatic arthritis and rheumatoid arthritis patients on anti-TNF treatment in clinical remission.
Ramírez J; Inciarte-Mundo J; Cuervo A; Ruiz-Esquide V; Hernández MV; Sanmartí R; Cañete JD
Clin Exp Rheumatol; 2017; 35(1):74-79. PubMed ID: 27749227
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study.
Chimenti MS; Ortolan A; Lorenzin M; Triggianese P; Talamonti M; Costa L; Caso F; Favero M; Teoli M; Galluzzo M; Scarpa R; Punzi L; Perricone R; Ramonda R
Clin Rheumatol; 2018 Feb; 37(2):397-405. PubMed ID: 29302829
[TBL] [Abstract][Full Text] [Related]
11. Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible.
Palsson O; Love TJ; Gunnarsdottir AI; Gunnarsson PS; Runarsdottir EE; Krogh NS; Gudbjornsson B
RMD Open; 2019; 5(2):e000984. PubMed ID: 31413869
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound composite scores for the assessment of inflammatory and structural pathologies in Psoriatic Arthritis (PsASon-Score).
Ficjan A; Husic R; Gretler J; Lackner A; Graninger WB; Gutierrez M; Duftner C; Hermann J; Dejaco C
Arthritis Res Ther; 2014 Oct; 16(5):476. PubMed ID: 25361855
[TBL] [Abstract][Full Text] [Related]
13. Minimal Disease Activity as a Treatment Target in Psoriatic Arthritis: A Review of the Literature.
Gossec L; McGonagle D; Korotaeva T; Lubrano E; de Miguel E; Østergaard M; Behrens F
J Rheumatol; 2018 Jan; 45(1):6-13. PubMed ID: 29142032
[TBL] [Abstract][Full Text] [Related]
14. High incidence of disease recurrence after discontinuation of disease-modifying antirheumatic drug treatment in patients with psoriatic arthritis in remission.
Araujo EG; Finzel S; Englbrecht M; Schreiber DA; Faustini F; Hueber A; Nas K; Rech J; Schett G
Ann Rheum Dis; 2015 Apr; 74(4):655-60. PubMed ID: 24336010
[TBL] [Abstract][Full Text] [Related]
15. Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial.
Kirkham B; de Vlam K; Li W; Boggs R; Mallbris L; Nab HW; Tarallo M
Clin Exp Rheumatol; 2015; 33(1):11-9. PubMed ID: 25535650
[TBL] [Abstract][Full Text] [Related]
16. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA).
Theander E; Husmark T; Alenius GM; Larsson PT; Teleman A; Geijer M; Lindqvist UR
Ann Rheum Dis; 2014 Feb; 73(2):407-13. PubMed ID: 23355078
[TBL] [Abstract][Full Text] [Related]
17. Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis-study protocol for the MONITOR-PsA study, a trials within cohorts study design.
Rombach I; Tillett W; Jadon D; Tucker L; Watson M; Francis A; Sinomati Y; Eldridge L; Dritsaki M; Dutton SJ; Al-Mossawi H; Gullick N; Thompson B; Coates LC
Trials; 2021 Mar; 22(1):185. PubMed ID: 33663566
[TBL] [Abstract][Full Text] [Related]
18. The Psoriatic Arthritis Registry of Turkey: results of a multicentre registry on 1081 patients.
Kalyoncu U; Bayindir Ö; Ferhat Öksüz M; Doğru A; Kimyon G; Tarhan EF; Erden A; Yavuz Ş; Can M; Çetin GY; Kılıç L; Küçükşahin O; Omma A; Ozisler C; Solmaz D; Bozkirli ED; Akyol L; Pehlevan SM; Gunal EK; Arslan F; Yılmazer B; Atakan N; Aydın SZ;
Rheumatology (Oxford); 2017 Feb; 56(2):279-286. PubMed ID: 27794533
[TBL] [Abstract][Full Text] [Related]
19. Impact of a magnetic resonance imaging-guided treat-to-target strategy on disease activity and progression in patients with rheumatoid arthritis (the IMAGINE-RA trial): study protocol for a randomized controlled trial.
Møller-Bisgaard S; Hørslev-Petersen K; Ejbjerg BJ; Boesen M; Hetland ML; Christensen R; Møller J; Krogh NS; Stengaard-Pedersen K; Østergaard M
Trials; 2015 Apr; 16():178. PubMed ID: 25896862
[TBL] [Abstract][Full Text] [Related]
20. The effects of structural damage on functional disability in psoriatic arthritis.
Kerschbaumer A; Baker D; Smolen JS; Aletaha D
Ann Rheum Dis; 2017 Dec; 76(12):2038-2045. PubMed ID: 28835465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
